Shopping Cart
Remove All
Your shopping cart is currently empty
NV03 is a selective antagonist of the UHRF1-H3K9me3 interaction (Kd=2.4 μM), binding to the UHRF1 tandem Tudor domain (TTD) to form a complex. It is suitable for cancer research. NV03 also functions as a ligand for E3 ligases in PROTAC synthesis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $165 | - | In Stock | |
| 5 mg | $413 | - | In Stock | |
| 10 mg | $689 | - | In Stock | |
| 25 mg | $1,360 | - | In Stock |
| Description | NV03 is a selective antagonist of the UHRF1-H3K9me3 interaction (Kd=2.4 μM), binding to the UHRF1 tandem Tudor domain (TTD) to form a complex. It is suitable for cancer research. NV03 also functions as a ligand for E3 ligases in PROTAC synthesis. |
| Targets&IC50 | UHRF1:2.4 μM (Kd) |
| Synonyms | GIP (1-42)TFA, GIP (1-42), porcine TFA |
| Molecular Weight | 389.52 |
| Formula | C19H27N5O2S |
| Cas No. | 2448341-58-8 |
| Smiles | CCN(CC)CCCNC(=O)Cn1nc(C)n2c3ccsc3c(C)c2c1=O |
| Relative Density. | 1.29 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | keep away from moisture,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.